Wiskott-Aldrich Syndrome Protein (WASp)

WASp is an essential regulatory protein whose primary role is to control the organization of the cell’s cytoskeleton. It is found exclusively in hematopoietic cells, meaning cells that originate in the blood-forming system, including blood cells and immune cells. Within these cells, WASp influences actin filaments, which are a central component of the cellular cytoskeleton. Through this function, it enables cells to change shape, move throughout the body, adhere to other cells, and communicate with them.

WASp serves as a mediator between signals the cell receives from its external environment and the internal mechanisms that shape the cytoskeleton. When a cell receives a signal instructing it to move, change shape, or form contact with another cell, the WASp protein becomes activated and changes its structure. As a result, it activates a protein complex known as Arp2/3, which is responsible for creating new branches of actin filaments. This allows the cell to reorganize its internal structure and adapt its shape to the required function.

This process is particularly important in white blood cells and platelets. In white blood cells, it enables movement throughout the body, migration to sites of infection or injury, and interaction with other immune cells. In platelets, it enables shape changes, adhesion to damaged blood vessels, and attachment to one another, thereby forming an initial blood clot that helps stop bleeding.

The importance of WASp becomes especially clear when the protein does not function properly. Defects in WASp can lead to Wiskott-Aldrich syndrome, a rare genetic disease that affects both the immune system and blood platelets. As a result, patients may suffer from recurrent infections and an increased tendency to bleed.

Understanding the role of the WASp protein has contributed significantly to improving the diagnosis and treatment of diseases associated with defects in this protein. Today, it is possible to identify mutations in the gene responsible for producing WASp, measure the protein’s levels within cells, and more accurately assess the severity of the disease. This knowledge has also supported the development of advanced treatments, including hematopoietic stem cell transplantation from a healthy donor, which can rebuild a functional immune system. At the same time, the field of gene therapy is also advancing. In this approach, patients’ cells are supplied with a healthy copy of the defective gene, enabling them to produce the normal WASp protein and improve immune system function.

Beyond these therapeutic approaches, recent studies are exploring how the mechanism of WASp itself might be harnessed for new treatments. In a study conducted at the Dangoor Center for Personalized Medicine, researchers investigated the activation of WASp in immune cells known as macrophages, with the goal of enhancing their ability to recognize and engulf cancer cells. The study demonstrated improved anti-tumor activity; however, this remains an early-stage research direction and is not yet available as a standard treatment for patients.

Frequently Asked Questions

1. What is the WASp protein?

WASp (Wiskott-Aldrich Syndrome protein) is an intracellular regulatory protein expressed in hematopoietic cells, meaning cells of the blood and immune systems. Its primary role is to regulate the organization of the cellular cytoskeleton by activating mechanisms that promote the remodeling of actin filaments. This enables cells to change shape, move, interact with other cells, and respond appropriately to external signals.

2. In which cells of the body is the WASp protein expressed?

WASp is expressed specifically in cells derived from the hematopoietic system, including various types of white blood cells as well as blood platelets. As a result, defects in the protein mainly affect immune system function and platelet activity.

3. What is the connection between WASp and the cytoskeleton?

The WASp protein helps organize the cellular cytoskeleton, which is built largely from actin filaments. It transmits signals from the cell membrane to the internal mechanisms responsible for generating and reorganizing actin filaments as needed. In this way, WASp enables cells to change shape, migrate, form contact with other cells, and carry out a variety of immune-related functions.

4. What is the significance of a deficiency in the WASp protein?

A deficiency in the WASp protein disrupts the normal function of immune cells and blood platelets. As a result, the body’s ability to fight infections is impaired, leading to an increased tendency toward recurrent infections and bleeding. The bleeding tendency is mainly caused by a reduced number of platelets and their unusually small size. Therefore, a deficiency in WASp has a combined effect on both immune defense and the blood-clotting process.

5. Why are defects in the WASp protein more common in males?

The WAS gene, which encodes the WASp protein, is located on the X chromosome. Since males have only one copy of the X chromosome, a mutation in the gene can directly lead to disease manifestation. Females usually have two X chromosomes, so in most cases the healthy copy compensates for the defective one. As a result, women are often carriers of the mutation, while the disease itself is more common in males.

6. What is the connection between the WASp protein and recurrent infections?

The WASp protein is essential for the normal activity of immune cells. When the protein is defective, these cells lose part of their ability to migrate toward sites of infection, establish effective contact with other immune cells, and respond properly to pathogens. As a result, the immune response becomes weakened, and patients may experience recurrent infections.

7. What is the difference between Wiskott-Aldrich syndrome and XLT?

Wiskott-Aldrich syndrome and XLT are two clinical conditions caused by mutations in the WAS gene. Both conditions involve abnormalities in blood platelets and may therefore lead to an increased tendency toward bleeding. The main difference between them lies in the severity: in Wiskott-Aldrich syndrome, the disorder is more extensive and includes immune deficiency, recurrent infections, and sometimes eczema. In XLT, by contrast, the condition is generally milder and is expressed mainly as thrombocytopenia.

8. How are defects in the WASp protein treated?

Treatment for defects in the WASp protein depends on the severity of the disease and the patient’s clinical symptoms. Alongside supportive care, which may include infection prevention, treatment of bleeding episodes, and monitoring for complications, there are also therapies aimed at correcting the underlying cause. The standard curative treatment is hematopoietic stem cell transplantation from a suitable donor, which can restore blood cell production and rebuild normal immune system function. In recent years, gene therapy has also advanced as a treatment approach. This method is based on introducing a healthy copy of the gene into the patient’s own stem cells.